Show simple item record

dc.contributor.authorButterfield, R.
dc.contributor.authorBarratt, Monica
dc.contributor.authorEzard, N.
dc.contributor.authorDay, R.
dc.date.accessioned2017-01-30T13:14:41Z
dc.date.available2017-01-30T13:14:41Z
dc.date.created2016-04-19T19:30:35Z
dc.date.issued2016
dc.identifier.citationButterfield, R. and Barratt, M. and Ezard, N. and Day, R. 2016. Drug checking to improve monitoring of new psychoactive substances in Australia. Medical Journal of Australia. 204 (4): pp. 144-145.
dc.identifier.urihttp://hdl.handle.net/20.500.11937/29714
dc.identifier.doi10.5694/mja15.01058
dc.description.abstract

As has been reported previously in the Journal, 1 novel psychoactive stimulant drugs are now increasingly prevalent in patients presenting to hospital emergency departments. A further cluster of 11 patients showing confusing hallmarks of sympathomimetic poisoning but no identifiable substance presented to St Vincent ’ s Hospital in Sydney over a public holiday weekend in April 2015. Also, the start to the 2015 e 2016 summer festival season has included multiple deaths and hospitalisations following drug use at festivals, leading to calls for novel actions to protect public health. 2 Here, we take the opportunity to describe a method of harm minimisation that has been deployed in Europe and could potentially be deployed locally to tackle this problem. As has been reported previously in the Journal, 1 novel psychoactive stimulant drugs are now increasingly prevalent in patients presenting to hospital emergency departments. A further cluster of 11 patients showing confusing hallmarks of sympathomimetic poisoning but no identifiable substance presented to St Vincent ’ s Hospital in Sydney over a public holiday weekend in April 2015. Also, the start to the 2015 e 2016 summer festival season has included multiple deaths and hospitalisations following drug use at festivals, leading to calls for novel actions to protect public health. 2 Here, we take the opportunity to describe a method of harm minimisation that has been deployed in Europe and could potentially be deployed locally to tackle this problem.

dc.publisherAustralasian Medical Publishing
dc.titleDrug checking to improve monitoring of new psychoactive substances in Australia
dc.typeJournal Article
dcterms.source.volume204
dcterms.source.number4
dcterms.source.startPage144
dcterms.source.endPage145
dcterms.source.issn1326-5377
dcterms.source.titleMedical Journal of Australia
curtin.note

© Copyright 2016. The Medical Journal of Australia - reproduced with permission

curtin.departmentNational Drug Research Institute (NDRI)
curtin.accessStatusOpen access


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record